Sharekhan

Data is delayed. Analysis is best done in real-time! Open a FREE Sharekhan Demat A/c in 15 mins* and continue your analysis with real-time data.

Market Data

Essential tool: analyze, trade, manage, decide.

What’s Your Call?

Collective community sentiment on Beta Drugs Ltd

Your Vote -

Buy

71.43%

Hold

14.29%

Sell

14.29%

71.43%

7 users have voted

Market Depth

How many stocks are available to buy or sell and at what prices.

Buy Order Quantity

0%

Sell Order Quantity

100%

Bid Price

Qty

0.00

0

0.00

0

0.00

0

0.00

0

0.00

0

Bid Total

0

Bid Price

Qty

1884.45

105

0.00

0

0.00

0

0.00

0

0.00

0

Bid Total

105

Option Chain

Analyzes market sentiment, predicts Beta Drugs Ltd' movement.

NO_RECORD_FOUND

News

Media spotlight triggers stock stock attention, sentiment.

  • Beta Drugs - Structural Digital Database

    29 May 2025, 5:45PM Structural Digital Database Compliance Certificate for year ended March 31, 2025
  • Beta Drugs - Analysts/Institutional Investor Meet/Con. Call Updates

    23 May 2025, 8:10PM Beta Drugs Limited has informed the Exchange about Transcript
  • Beta Drugs - Analysts/Institutional Investor Meet/Con. Call Updates

    16 May 2025, 6:09PM Beta Drugs Limited has informed the Exchange about Link of Recording
  • Beta Drugs - Analysts/Institutional Investor Meet/Con. Call Updates

    15 May 2025, 9:47PM Beta Drugs Limited has informed the Exchange about Presentation
  • Beta Drugs - Statement of deviation(s) or variation(s) under Reg. 32

    15 May 2025, 5:02PM Beta Drugs Limited has informed the Exchange about statement of deviation(s) or variation(s) under Reg. 32
  • Beta Drugs - Monitoring Agency Report

    15 May 2025, 5:01PM Monitoring Agency Report for the half year ended March 31, 2025
  • Beta Drugs - Outcome of Board Meeting

    15 May 2025, 3:28PM Beta Drugs Limited has informed the Exchange regarding Outcome of Board Meeting held on May 15, 2025.
  • Beta Drugs - Analysts/Institutional Investor Meet/Con. Call Updates

    12 May 2025, 3:36PM Beta Drugs Limited has informed the Exchange about Schedule of meet
  • Beta Drugs - Board Meeting Intimation

    9 May 2025, 5:22PM BETA DRUGS LIMITED has informed the Exchange about Board Meeting to be held on 15-May-2025 to inter-alia consider and approve the Audited Financial re
  • Beta Drugs - Updates

    5 May 2025, 9:00AM Beta Drugs Limited has informed the Exchange regarding 'Beta Drugs completes COFEPRIS for its Oncology formulation & API manufacturing plants'.
  • Beta Drugs has submitted to BSE the Shareholding Pattern for the Period Ended March 27, 2025

    22 Apr 2025, 7:00AM As of March 2025, 66.73% is owned by Indian Promoters and 33.27% by Public. <p align=justify> Top five Promoters holding highest number of shares of B
  • Beta Drugs has submitted to BSE the Shareholding Pattern for the Period Ended March 31, 2025

    16 Apr 2025, 8:50PM As of March 2025, 66.73% is owned by Indian Promoters and 33.27% by Public. <p align=justify> Top five Promoters holding highest number of shares of B
  • Beta Drugs - Certificate under SEBI (Depositories and Participants) Regulations, 2018

    8 Apr 2025, 4:49PM Beta Drugs Limited has informed the Exchange about Certificate under SEBI (Depositories and Participants) Regulations, 2018
  • Beta Drugs - Disclosure under SEBI Takeover Regulations

    8 Apr 2025, 2:25PM Beta Drugs Limited has Submitted to the Exchange a copy of Disclosure under Regulation 31(4) of the Securities and Exchange Board of India (Substantia
  • Beta Drugs - Trading Window-XBRL

    29 Mar 2025, 12:52PM BETA DRUGS LIMITED has informed the Exchange about Closure of Trading Window
  • Beta Drugs - Trading Window

    29 Mar 2025, 12:49PM Beta Drugs Limited has informed the Exchange regarding the Trading Window closure pursuant to SEBI (Prohibition of Insider Trading) Regulations, 2015
  • Beta Drugs - Alteration Of Capital and Fund Raising-XBRL

    27 Mar 2025, 10:08AM BETA DRUGS LIMITED has informed the Exchange regarding Allotment of Securities
  • Beta Drugs - Outcome of Board Meeting

    27 Mar 2025, 10:06AM Beta Drugs Limited has informed the Exchange regarding Board meeting held on March 27, 2025-allotment of 4,80,693 fully paid-up equity shares of the
  • Beta Drugs - Updates

    19 Mar 2025, 5:47PM Beta Drugs Limited has informed the Exchange regarding ''the Board meeting to be held on 27th March, 2025 to interalia, transact the following busines
  • Beta Drugs - Board Meeting Intimation

    19 Mar 2025, 5:40PM BETA DRUGS LIMITED has informed the Exchange about Board Meeting to be held on 27-Mar-2025 to consider Other business.
  • Beta Drugs - Copy of Newspaper Publication

    19 Mar 2025, 10:40AM Beta Drugs Limited has informed the Exchange about Copy of Newspaper Publication-Record date for Bonus Shares
  • Beta Drugs - Record Date

    18 Mar 2025, 10:07AM Beta Drugs Limited has informed the Exchange that Record date for the purpose of Bonus is 26-Mar-2025.
  • Beta Drugs - Shareholders meeting

    12 Mar 2025, 4:38PM Beta Drugs Limited has submitted the Exchange a copy Srutinizers report of Postal Ballot. Further, the company has informed the Exchange regarding vo
  • Beta Drugs - General Updates

    12 Mar 2025, 4:33PM Beta Drugs Limited has informed the Exchange about General Updates--Proceedings of Postal Ballot
  • Beta Drugs - Amendment to AOA/MOA

    12 Mar 2025, 4:26PM Beta Drugs Limited has informed the Exchange regarding the Amendment to AOA/MOA of the company.
  • Beta Drugs - Shareholders meeting

    12 Mar 2025, 4:13PM Beta Drugs Limited has informed the Exchange regarding Proceedings of Postal Ballot. Further, the company has submitted the Exchange a copy of Srutini

Key fundamentals

Evaluate the intrinsic value of Beta Drugs Ltd stock 

Name March-25 March-24 March-23 March-22 March-21
Assets 119.63 119.6301 99.984 82.6124 67.304
Liabilities 119.63 119.6301 99.984 82.6124 67.304
Equity 9.6137 9.6138 9.6138 9.6138 9.6137
Gross Profit 31.416 33.5256 31.1981 25.1837 15.3099
Net Profit 15.4321 21.9366 18.8161 14.2465 6.9777
Cash From Operating Activities 21.1871 21.1872 10.2264 18.7625 11.5987
NPM(%) 7 11.1 11.91 11.41 8.78
Revenue 220.1996 197.6207 157.8746 124.8468 79.4564
Expenses 188.7835 164.0951 126.6765 99.6631 64.1464
ROE(%) 8.53 12.12 10.4 7.87 3.85

Shareholding Pattern

Corporate Action

XD-Date Dividend-Amount Dividend-% Dividend Yield(%GE) Price on that day

Peers

Other companies within the same industry or sector that are comparable to Beta Drugs Ltd

Company Price Price (% change) pe(x) EV/EBITDA(x) ROE(%) ROCE(%)
Albert David Ltd 802.25 -0.44 26.62 0.00 301.39 0.62
Lotus Eye Hospital and Institute Ltd 71.90 -0.18 205.43 0.00 3.55 0.00
Vaishali Pharma Ltd 12.69 -0.16 211.50 0.00 3.13 0.00
Astec Lifesciences Ltd 672.20 -0.91 0.00 0.00 -687.10 0.00

Company Info

The Company was incorporated as ?Beta Drugs Private limited? at Himachal Pradesh as a private limited company under the provisions of the Companies Act, 1956 vide Certificate of Incorporation dated September 21, 2005 bearing Corporate Identification Number U24230HP2005PTC28969 issued by Registrar of Companies, Punjab, Himachal Pradesh and Chandigarh. Subsequently, the Company was converted in to public limited company pursuant to Shareholders Resolution passed at the Extra-Ordinary General Meeting of the Company held on July 24, 2017 and the name of the Company was changed to ?Beta Drugs Limited? pursuant to issuance of fresh Certificate of Incorporation consequent upon conversion of Company from Private to Public Limited dated August 11, 2017 issued by the Registrar of Companies, Himachal Pradesh. The Corporate Identification Number of the Company is U24230HP2005PLC028969. KEY EVENTS AND MILESTONES IN THE HISTORY OF THE COMPANY 2005 -Incorporation of the Company as Beta Drugs Private Limited 2014 -Vijay Kumar Batra, existing promoter took over the Company 2015 -ISO: 9001:2008 Certification for manufacturing and supply of Pharmaceutical products such as Oncology Sterile Injections and Lyophilized Injections and Oncology solid oral medication tablets and capsules -Certificate of Good Manufacturing Practice from Health and Family Welfare Department, Himachal Pradesh 2016 -Certificate of Good Manufacturing Practice from Republic of Kenya 2017 -Conversion of Company into Public Limited Company. 2024 -The Company Earns Forbes Asia ""Best Under a Billion"" 2024 Award for Third Consecutive Year,

The Company was incorporated as ?Beta Drugs Private limited? at Himachal Pradesh as a private limited company under the provisions of the Companies Act, 1956 vide Certificate of Incorporation dated September 21, 2005 bearing Corporate Identification Number U24230HP2005PTC28969 issued by Registrar of Companies, Punjab, Himachal Pradesh and Chandigarh. Subsequently, the Company was converted in to public limited company pursuant to Shareholders Resolution passed at the Extra-Ordinary General Meeting of the Company held on July 24, 2017 and the name of the Company was changed to ?Beta Drugs Limited? pursuant to issuance of fresh Certificate of Incorporation consequent upon conversion of Company from Private to Public Limited dated August 11, 2017 issued by the Registrar of Companies, Himachal Pradesh. The Corporate Identification Number of the Company is U24230HP2005PLC028969. KEY EVENTS AND MILESTONES IN THE HISTORY OF THE COMPANY 2005 -Incorporation of the Company as Beta Drugs Private Limited 2014 -Vijay Kumar Batra, existing promoter took over the Company 2015 -ISO: 9001:2008 Certification for manufacturing and supply of Pharmaceutical products such as Oncology Sterile Injections and Lyophilized Injections and Oncology solid oral medication tablets and capsules -Certificate of Good Manufacturing Practice from Health and Family Welfare Department, Himachal Pradesh 2016 -Certificate of Good Manufacturing Practice from Republic of Kenya 2017 -Conversion of Company into Public Limited Company. 2024 -The Company Earns Forbes Asia ""Best Under a Billion"" 2024 Award for Third Consecutive Year,

Read More

Parent Organisation

Beta Drugs Ltd.

Founded

21/09/2015

Managing Director

Mr.Varun Batra

NSE Symbol

BETASM

FAQ

The current price of Beta Drugs Ltd is

The 52-week high for Beta Drugs Ltd is

The market capitalization of Beta Drugs Ltd is currently This value can fluctuate based on stock price movements and changes in the number of shares outstanding.

To buy Beta Drugs Ltd shares, you need to have a brokerage account. First, choose a reputable brokerage firm, open an account, and complete the necessary KYC procedures.

To invest in Beta Drugs Ltd, you need a brokerage account. After opening an account and completing the KYC process, you can fund your account and use the trading platform to purchase Beta Drugs Ltd shares.

The CEO of Beta Drugs Ltd is Mr.Varun Batra, who has been leading the company with a vision to expand its renewable energy portfolio and drive sustainable growth.

OPEN FREE* DEMAT ACCOUNT